Synthesized PKM2 activators
Key Dates
Due Date
-
Posted Date
-
Agency & Value
Agency
NATIONAL INSTITUTES OF HEALTH NIDA
Contract Value
Not provided
Codes & Classification
Solicitation Number
75N95021Q00202
NAICS
325199 - All Other Basic Organic Chemical Manufacturing
Classification Code
6810
Additional Details
The National Institutes of Health (NIH), specifically the National Institute on Drug Abuse (NIDA), has issued a combined synopsis/solicitation for the procurement of synthesized PKM2 activators. This opportunity, identified by solicitation number 75N95021Q00202, is a request for quotation (RFQ) for commercial items, prepared in accordance with FAR Subpart 12.6 and conducted under the simplified acquisition procedures of FAR Part 13. The procurement is set aside exclusively for small businesses under NAICS code 325199 (All Other Basic Organic Chemical Manufacturing), with a size standard of 1,250 employees.
Purpose and Scope:
The primary objective of this procurement is to support ongoing research at the NIH’s National Center for Advancing Translational Sciences (NCATS) into small molecule activators of the M2 isoform of pyruvate kinase (PKM2). Prior work at NCATS has identified compounds such as TEPP-46 and its structural analogs as potent PKM2 activators, which have demonstrated promising results in preclinical models of cancer, inflammation, and diabetes. The current requirement seeks to further optimize these compounds by acquiring specific analogs and investigational agents for comparative studies and potential advancement toward clinical candidates.
Key Requirements and Deliverables:
The contractor is required to synthesize and deliver the following quantities of specified compounds:
- One (1) gram each of NCGC00344932 and NCGC00319092 (structural analogs of TEPP-46)
- 200 milligrams each of lead investigational agents TP-1158 and FT-4202
The chemical structures for these compounds are provided in Attachment 1 of the solicitation. In addition to the physical delivery of the compounds, the contractor must submit synthetic plans and a comprehensive report via email to the designated NCATS points of contact. All deliverables are to be shipped FOB destination to 9800 Medical Center Drive, Rockville, MD 20850, within six months from the date of award.
Contracting Entity and Contact Information:
The contracting entity is the NIH NIDA, operating under the Department of Health and Human Services. The primary point of contact for this solicitation is Kimberly Espinosa, Contracting Officer, who can be reached at 301-827-3546 or via email at [email protected].
Procurement Type and Special Considerations:
This is a competitive, small business set-aside procurement, and the government intends to award a fixed-price purchase order. The anticipated award date is June 10, 2021. The award will be made to the vendor offering the best value to the government, considering technical capability, past performance, and price. Comparative evaluations will be used to determine the best value.
Submission Instructions:
Quotations must be submitted by 3:00pm Eastern Time on June 4, 2021, referencing the solicitation number. Submissions should be sent via email to Kimberly Espinosa. Responses must include sufficient information to demonstrate bona fide capabilities, and may exceed the solicitation’s requirements if such enhancements provide a benefit to the government. Required documentation includes DUNS, TIN, business size certification, completed FAR representations (52.204-24, 52.204-26, 52.225-2), and a detailed quotation covering total and individual line item pricing, payment terms, product descriptions, and any relevant factors such as warranty, maintenance, and environmental considerations.
Constant Elements:
Throughout the contract lifecycle, the scope will remain focused on the synthesis and delivery of specified PKM2 activators, with strict adherence to the quantities, chemical specifications, and reporting requirements outlined in the solicitation. The delivery location, contracting entity, and small business set-aside status are fixed elements, as are the evaluation criteria and submission requirements.
This opportunity is well-suited for small businesses specializing in organic chemical manufacturing, particularly those with expertise in custom synthesis of pharmaceutical-grade compounds. Interested contractors should carefully review the solicitation and attachments to ensure alignment with their capabilities and compliance with all requirements.
Documents7